Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale EVP, Research & CSO sold 1,755 shares at $38.00 ($66,690)
  5. 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $30.07 ($114,418)
  6. 4 Open-market sale Chief Business Officer sold 75,000 shares at $30.05 ($2,253,885)
  7. 4/A Insider Changes in Ownership
  8. 4 Open-market sale Director sold 18,458 shares at an average $28.00 ($516,853)
  9. 4 Exercise or conversion Chief Medical Officer acquired 8,000 shares (option exercise)
  10. 4 Other disposition President and CEO disposed of 236,806 shares (other)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Director bought 1,000,000 shares at $20.00 ($20,000,000)
  14. 4 Open-market buy Director bought 1,000,000 shares at $20.00 ($20,000,000)
  15. 4 Open-market buy 10% owner bought 1,000,000 shares at $20.00 ($20,000,000)
  16. 4 Conversion Director acquired 222,220 shares (conversion)
  17. 4 Conversion Director acquired 2,005,265 shares (conversion)
  18. 4 Conversion Director acquired 218,400 shares (conversion)
  19. 4 Conversion Former 10% Holder acquired 1,666,666 shares (conversion)
  20. 4 Open-market buy 10% owner bought 500,000 shares at $20.00 ($10,000,000)

Page 23 of 25 · 491 filings